Emedastine - Moligand™, ≥97% , CAS No.87233-61-2

CAS: 87233-61-2 Cat. No.: E413308 Summenformel: C17H26N4O Molekulargewicht: 302.41
Zu bestellen verfügbar
QUALITÄT & REINHEIT Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥97%
Synonyms
1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-1,3-benzodiazole|1-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole|1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole|Emedastina|emedastine|Emedastine [INN:BAN]|EMEDASTINE [WHO-DD]|1-methyl-4-(1-(2-ethoxyethyl)-1H-benzimidazol-2-yl)[1,4]diazepane|Emedastinum|Emadine (TN)|1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-benzimidazole|1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole|EMEDASTINE [VANDF]|Emadine|1-Methyl-4-(1-(2-ethoxyethyl)-1H-benzimidazo)-2-yl)(1,4)diazepane|1-[2-(ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole|1H-Benzimidazole, 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-|Emedastinum [INN-Latin]|EMEDASTINE [MI]|Emedastine [INN]|EMEDASTINE [EMA EPAR]|1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1h-benzo[d]imidazole|Emedastine (INN)|1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl) benzimidazole
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Größe
Deutschland (EU)
USA*
Preis
Menge
5mg
E413308-5mg
—
3 Auf Lager
78,88€
25mg
E413308-25mg
Auf Bestellung · 8–12 Wochen
302,75€
100mg
E413308-100mg
—
2 Auf Lager
787,82€
Enter a quantity for the sizes you want to add.

Übersicht

Information

Emedastine is a potent, high affinityhistamine H1-receptor-selectiveantagonist with Ki of 1.3 ±0.1 nM for H1-receptors while considerably weaker at H2- (K1 = 49,067 ± 11,113 nM) and H3-receptors (Ki = 12,430 ± 1,282 nM).


Targets

H1 receptor (Cell-free assay) 1.3 nM(Ki)


In vitro

Emedastine is capable of potently inhibiting histamine-induced cytokine release as well as the chemotaxis of eosinophils, thereby influencing factors contributing to the inhibition of the signs and symptoms of allergic diseases.


In vivo

In human, the half-life of emedastine, when administered as slow release capsules is of about 6±7 h.

Spezifikationen

Synonyme
1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-1,3-benzodiazole | 1-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole | 1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole | Emedastina | emedastine | Emedastine [INN:BAN] | EMEDASTINE [WHO-DD] | 1-methyl-4-(1-(2-ethoxyethyl)-1H-benzimidazol-2-yl)[1,4]diazepa Show more
Spezifikationen & Reinheit
Moligand™, ≥97%
Biochemische und physiologische Mechanismen
Emedastine is a potent, high affinity histamine H1-receptor-selective antagonist with Ki of 1.3 ±0.1 nM for H1-receptors while considerably weaker at H2- (K1 = 49,067 ± 11,113 nM) and H3-receptors (Ki = 12,430 ± 1,282 nM).
Storage
Store at -20°C
Verschickt in
Ice chest + Ice pads
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Note
Moligand™
Reinheit
≥97%
Produkteigenschaften
ALogP
2.492
hba_count
2
Rotationsfähige Bindung
5
Namen und Kennungen
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/504750648
SMILES
CCOCCN1C2=CC=CC=C2N=C1N3CCCN(CC3)C
IUPAC Name
1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole
InChIKey
KBUZBQVCBVDWKX-UHFFFAOYSA-N
InChI
1S/C17H26N4O/c1-3-22-14-13-21-16-8-5-4-7-15(16)18-17(21)20-10-6-9-19(2)11-12-20/h4-5,7-8H,3,6,9-14H2,1-2H3
Isomere SMILES
CCOCCN1C2=CC=CC=C2N=C1N3CCCN(CC3)C
Molekulargewicht
302.41
Reaxys
6068161
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=6068161&ln=

Erweiterte Daten

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
KlasseBenzimidazoles
SubclassNot available
Intermediate Tree Nodes Not available
Direct ParentBenzimidazoles
Alternative Parents Dialkylarylamines  1,4-diazepanes  N-substituted imidazoles  Benzenoids  Aminoimidazoles  Heteroaromatic compounds  Trialkylamines  Dialkyl ethers  Azacyclic compounds  Organopnictogen compounds  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Benzimidazole - Dialkylarylamine - Diazepane - 1,4-diazepane - Aminoimidazole - N-substituted imidazole - Benzenoid - Imidazole - Azole - Heteroaromatic compound - Tertiary aliphatic amine - Tertiary amine - Ether - Dialkyl ether - Azacycle - Organic oxygen compound - Organooxygen compound - Organonitrogen compound - Amine - Organopnictogen compound - Organic nitrogen compound - Hydrocarbon derivative - Aromatic heteropolycyclic compound
BeschreibungThis compound belongs to the class of organic compounds known as benzimidazoles. These are organic compounds containing a benzene ring fused to an imidazole ring (five member ring containing a nitrogen atom, 4 carbon atoms, and two double bonds).
External Descriptors benzimidazoles
3D-Struktur
Interaktives chemisches Strukturmodell





Zugehörige Ziele (menschlich)
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PMP22 Tbio Peripheral myelin protein 22 (699 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GLS Tchem Glutaminase kidney isoform, mitochondrial (16997 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Zugehörige Ziele (nicht menschlich)
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Wirkungsmechanismen
Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

4 results found

Lot NumberCertificate TypeDatumArtikel
F2229337F2229337Certificate of AnalysisMar 13, 2026 E413308
F2229323F2229323Certificate of AnalysisJan 20, 2026 E413308
B2419137B2419137Certificate of AnalysisDec 10, 2025 E413308
F2229322F2229322Certificate of AnalysisJun 02, 2022 E413308
Chemische und physikalische Eigenschaften
LöslichkeitSolubility (25°C) In vitro      
DMSO (mM) Maximale Löslichkeit10
Molekulargewicht302.4
XLogP32.200
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count5
Exact Mass302.211 Da
Monoisotopic Mass302.211 Da
Topological Polar Surface Area33.500 Ų
Heavy Atom Count22
Formal Charge0
Complexity341.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Sicherheit und Gefahren (GHS)
Signal
Warning
Gefahrenhinweise

H302:Harmful if swallowed

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

Sicherheitshinweise

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P301+P312:IF SWALLOWED: call a POISON CENTER/doctor/... IF you feel unwell.

P302+P352:IF ON SKIN: wash with plenty of water.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

Reaxys
6068161
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=6068161&ln=
Lösungsrechner
Bewertungen

Kundenbewertungen

Benötigen Sie Hilfe bei der Auswahl der Qualität?

Unser Leitfaden zur Qualitätsauswahl behandelt Reinheit, Stabilisatorstatus und Anwendungseignung für alle Varianten in unserem Katalog.

Moligand™ Qualitätsleitfaden ansehen →

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.